Glaxosmithkline Pharmaceuticals Ltd Half Yearly Results

Gross Sales

1,825.42

1,735.06

1,718.65

1,589.75

1,661.97

Excise Duty

0

0

0

0

0

Net Sales

1,825.42

1,735.06

1,718.65

1,589.75

1,661.97

Other Operating Income

0

0

0

0

0

Other Income

74.87

40.64

81.95

51.08

52.63

Total Income

1,900.29

1,775.7

1,800.6

1,640.83

1,714.6

Total Expenditure

1,273.17

1,403.35

1,285.28

1,192.28

1,256.12

PBIDT

627.12

372.35

515.32

448.55

458.48

Interest

0.64

1.09

0.71

0.74

1.07

PBDT

626.48

371.26

514.61

447.81

457.41

Depreciation

33.27

35.21

34.47

33.59

32.18

Minority Interest Before NP

0

0

0

0

0

Tax

162.32

93.08

144.51

126.5

120.63

Deferred Tax

-3.94

2.77

-14.13

-10.27

-8.1

Reported Profit After Tax

434.83

240.2

349.76

297.99

312.7

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

434.83

240.2

349.76

297.99

312.7

Extra-ordinary Items

3.41

-160.91

12.09

-0.97

3.05

Adjusted Profit After Extra-ordinary item

431.42

401.11

337.67

298.96

309.65

EPS (Unit Curr.)

25.43

14.18

19.88

17.59

18.46

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

120

0

320

0

0

Equity

169.41

169.41

169.41

169.41

169.41

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

34.35

21.46

29.98

28.21

27.58

PBDTM(%)

-

-

-

-

-

PATM(%)

23.82

13.84

20.35

18.74

18.81